These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 5520307)
1. [Theray of Parkinson-syndrome with Helfo-Dopa]. Roeder F Med Klin; 1970 Nov; 65(45):1983-7. PubMed ID: 5520307 [No Abstract] [Full Text] [Related]
2. Levodopa in Parkinsonism: potentiation of central effects with a peripheral inhibitor. Papavasiliou PS; Cotzias GC; Düby SE; Steck AJ; Fehling C; Bell MA N Engl J Med; 1972 Jan; 286(1):8-14. PubMed ID: 4550085 [No Abstract] [Full Text] [Related]
3. [L-DOPA therapy of parkinsonism]. Refsum S Nord Med; 1969 May; 81(18):570-1. PubMed ID: 5768311 [No Abstract] [Full Text] [Related]
4. L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects. Muenter MD; Tyce GM Mayo Clin Proc; 1971 Apr; 46(4):231-9. PubMed ID: 5573818 [No Abstract] [Full Text] [Related]
5. [Biochemical bases for the treatment of Parkinson's syndrome with L-dopa]. Pletscher A; Bartholini G; Gey KF; Jenni A Schweiz Med Wochenschr; 1970 May; 100(19):797-804. PubMed ID: 4924275 [No Abstract] [Full Text] [Related]
6. [Current treatment of Parkinson syndrome with L-dopa]. Gerstendbrand F; Gründig E; Musiol A Pol Tyg Lek; 1972 May; 27(21):798-800. PubMed ID: 4555002 [No Abstract] [Full Text] [Related]
7. [Treatment of Parkinson's disease with L-dopa]. Guglielmi L; Vecchi L Clin Ter; 1970 May; 53(3):259-69. PubMed ID: 4917328 [No Abstract] [Full Text] [Related]
8. The Eaton Collaborative Study of levodopa therapy in parkinsonism: a summary. Keenan RE Neurology; 1970 Dec; 20(12):46-59. PubMed ID: 5531294 [No Abstract] [Full Text] [Related]
9. L-dopa therapy in parkinsonism: mechanism of action. Sandler M Psychiatr Neurol Neurochir; 1971; 74(4):331-3. PubMed ID: 5146239 [No Abstract] [Full Text] [Related]
10. L-dopa in Parkinson's disease. A report on 95 cases and review of the literature. Lewis I J Med Assoc State Ala; 1971 May; 40(11):709-18. PubMed ID: 5573008 [No Abstract] [Full Text] [Related]
11. [L-dopa and Parkinson's disease]. Barbeau A Union Med Can; 1970 Dec; 99(12):2195-7. PubMed ID: 5488646 [No Abstract] [Full Text] [Related]
13. [Clinical effect of L-DOPA and electromyographic study of Parkinsonism]. Sato G; Ito H; Handa Y; Takahashi I; Iijima K No To Shinkei; 1971 Mar; 23(3):325-32. PubMed ID: 5107821 [No Abstract] [Full Text] [Related]
14. The metabolism of orally administered L-dopa in Parkinson patients. Cote LJ; Cohen G; Yahr MD Trans Am Neurol Assoc; 1971; 96():222-3. PubMed ID: 5159086 [No Abstract] [Full Text] [Related]
15. Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486). Yahr MD; Duvoisin RC; Mendoza MR; Schear MJ; Barrett RE Trans Am Neurol Assoc; 1971; 96():55-8. PubMed ID: 5159129 [No Abstract] [Full Text] [Related]
16. [Treatment of Parkinsonism with L-dopa--with special reference to clinical effects, side effects and urinary metabolites of catecholamines]. Uono M; Tanabe H; Yano Y; Nakao K No To Shinkei; 1970 Sep; 22(9):1091-101. PubMed ID: 5536082 [No Abstract] [Full Text] [Related]